Futamura M, Ishihara K, Nagao Y, Ogiso A, et al. Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04). Breast Cancer 2023 Jan 7. doi: 10.1007/s12282-022-01425.
PMID: 36609911